Platelet Aggregation Devices Market Is Projected To Top A Valuation Of US$ 1 Billion By The End Of 2031

This new Fact.MR study predicts the sales of platelet aggregation devices to rise at a phenomenal CAGR of 20% from 2022 to 2027. As such, the global platelet aggregation devices market is estimated to surge to over US$ 1 billion by the end of 2027.

Download Sample Copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7657

High prevalence of blood disorders coupled with rising healthcare expenditure is expected to drive platelet aggregation device demand. Supportive government initiatives, rapid technological advancements, high incidence of cardiovascular disorders, and a growing aging population are other factors that will drive platelet aggregation devices market growth over the years to come.

This new platelet aggregation devices market research analysis by analysts at Fact.MR, a market research and competitive intelligence provider, has profiled key companies such as F. Hoffmann-La Roche Ltd., Instrumentation Laboratory, Haemonetics Corporation, Siemens Healthcare GmbH, SENTINEL CH. SpA, Werfen, Pathway Diagnostics Limited, Haemochrom Diagnostica GmbH, and Tem Group.

Ask an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=7657

Key Takeaways from Market Study

• At present, the global platelet aggregation devices market enjoys a valuation of US$ 421 million.
• Demand for platelet aggregation devices is anticipated to surge at an astounding CAGR of 20% over the next five years.
• By 2027, sales revenue of the platelet aggregation devices market is expected to be US$ 1.05 billion.
• Advancements in platelet aggregation system technologies, rising healthcare expenditure, growing geriatric population, increasing investments in healthcare R&D, and high prevalence of blood disorders are expected to favor platelet aggregation devices market growth.
• Sales of platelet aggregation systems are projected to rise at 20.7% CAGR and reach a valuation of US$ 500 million by the end of 2027.
• High cost of platelet aggregation systems, procedural limitations, and dearth of skilled professionals are anticipated to hurt platelet aggregation device growth to some extent.
• In 2022, the U.S. platelet aggregation devices market stands at US$ 105 million.
• Demand for platelet aggregation equipment in Germany is set to increase at a CAGR of 15% through 2027.

"Growing incidence of blood disorders is expected to primarily sculpt platelet aggregation devices market growth potential over the next five years,"
says a Fact.MR analyst

Get Access of Complete Report: https://www.factmr.com/checkout/7657

Winning Strategy

Platelet aggregation device manufacturers are expected to eye mergers, collaborations, acquisitions, and partnerships to widen their business scope and increase their revenue generation capacity. Companies are also expected to increase their investments in the research and development sector to create new innovative products and solutions for platelet aggregation.
More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global platelet aggregation devices market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.

The study divulges essential insights on the market on the basis of product (systems, reagents, consumables & accessories), application (clinical, research), and end user (hospitals, diagnostic laboratories, other end users), across five major regions (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

Read More Trending Reports of Fact.MR-
https://www.globenewswire.com/news-release/2022/10/03/2526452/0/en/Sales-of-Laparotomy-Sponges-Are-Projected-to-Reach-a-Market-Size-of-US-1-6-billion-By-2027-Radiopaque-Laparotomy-Sponges-Widely-Used-in-Thoracic-Surgical-Procedures-Report-Fact-MR.html

https://www.prnewswire.com/news-releases/anesthesia-monitoring-devices-market-to-exceed-us-3-4-billion-by-2027-amid-rising-prevalence-of-degenerative-and-chronic-illnesses-301659609.html

https://www.globenewswire.com/en/news-release/2022/10/14/2534866/0/en/Automated-Microscopy-Gaining-Traction-in-Drug-Development-Processes-Fact-MR-Report.html

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.